Chemotherapy in experimental brain tumor, part 1: In vitro colorimetric MTT assay Christopher M. HandJohn R. VenderPerry Black OriginalPaper Pages: 1 - 6
Chemotherapy in experimental brain tumor, part 2: Pretreatment with leukotriene C4 prolongs survival Perry BlackChristopher M. HandSydney D. Finkelstein OriginalPaper Pages: 7 - 19
High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma P.A. ForsythT. Dickinson LaingD.R. Edwards OriginalPaper Pages: 21 - 29
Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration Giovanni TrediciStefano TrediciGuido Cavaletti OriginalPaper Pages: 31 - 40
In vivo etoposide-resistant C6 glioma cell line: Significance of altered DNA topoisomerase II activity in multi-drug resistance Takuyu TakiTakanori OhnishiToru Hayakawa OriginalPaper Pages: 41 - 53
Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging John M. GomoriNorman HechingTali Siegal OriginalPaper Pages: 55 - 60
Long-term survival in patients with supratentorial glioblastoma Maurizio SalvatiLuigi CervoniFranco Maria Gagliardi OriginalPaper Pages: 61 - 64
Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma Jan C. BucknerPatrick A. BurchBernd W. Scheithauer OriginalPaper Pages: 65 - 70
The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy Ching-Yeh HsiungStephen Wan LeungFu-Min Fang OriginalPaper Pages: 71 - 77
Primary intramedullary spinal melanoma: Diagnostic and treatment problems K. SalameO. MerimskyG.E. Ouaknine OriginalPaper Pages: 79 - 83
Nervous system involvement by metastatic hepatocellular carcinoma Manho KimDuk L NaJae-Kyu Roh OriginalPaper Pages: 85 - 90
Rat brain tumor models in experimental neuro-oncology:The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 Gliomas Rolf F. Barth OriginalPaper Pages: 91 - 102
